Boston Scientific
Boston Scientific, we work collaboratively to solve healthcare’s toughest problems by developing solutions that matter most to those suffering from debilitating.
- Healthcare
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
* | N/A | $2.0b | Post IPO Debt |
| Total Funding | 000k | ||
| USD | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | 20 % | 7 % | 12 % | 18 % | 16 % | 11 % | 10 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | 23 % | 22 % | 25 % | 26 % | 30 % | 30 % | 31 % |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | 9 % | 6 % | 11 % | 11 % | 14 % | 16 % | 17 % |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 10 % | 10 % | 10 % | 10 % | - | - | - |
Source: Company filings or news article, Equity research estimates
Related Content
Boston Scientific Corporation is a global leader in the development, manufacturing, and marketing of medical devices that are used in a broad range of interventional medical specialties. The company serves healthcare professionals and patients worldwide, focusing on areas such as cardiology, endoscopy, urology, and neuromodulation. Operating in the medical technology market, Boston Scientific's business model revolves around the continuous innovation of medical devices and solutions that address complex health conditions. Revenue is generated through the sale of these devices to hospitals, clinics, and other healthcare facilities. The company also invests heavily in research and development to maintain its competitive edge and expand its product portfolio.
Keywords: medical devices, cardiology, endoscopy, urology, neuromodulation, healthcare, innovation, research, development, global.
Tech stack
